Browsing Tag
MedQuímica Indústria Farmacêutica
2 posts
Is this Lupin’s next U.S. respiratory blockbuster? Generic Perforomist hits the shelves
Lupin launches generic Perforomist in the U.S. for asthma and COPD, eyeing a $268M market. Find out how this move boosts its global respiratory portfolio.
Lupin subsidiary MedQuímica buys rights to nine drugs from Bausch Health
Lupin Limited said that MedQuímica Indústria Farmacêutica, its 100% subsidiary in Brazil, has agreed to acquire all rights…